IRUPLINALKIB

Clinical trials for IRUPLINALKIB explained in plain language.

Never miss a new study

Get alerted when new IRUPLINALKIB trials appear

Sign up with your email to follow new studies for IRUPLINALKIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for lung cancer patients who run out of options

Disease control Recruiting now

This study is observing how well a newer drug called iruplinalkib works for people with advanced ALK-positive lung cancer who have already tried and stopped responding to a standard drug called lorlatinib. It will follow about 20 patients in real-world hospital settings to see ho…

Matched conditions: IRUPLINALKIB

Sponsor: Peking University Shenzhen Hospital • Aim: Disease control

Last updated Mar 24, 2026 12:01 UTC

IRUPLINALKIB

Get alerted when new IRUPLINALKIB trials appear

New hope for lung cancer patients who run out of options